24 Jun 2021 12:26
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 23 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,739,268 | 1.35% | 242,393 | 0.19% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 94,581 | 0.07% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
1,817,727 | 1.41% | 343,074 | 0.27% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 231.2500 USD |
Purchase | 2 | 231.3200 USD |
Purchase | 2 | 230.8450 USD |
Purchase | 2 | 231.1800 USD |
Purchase | 6 | 231.0050 USD |
Purchase | 6 | 231.2783 USD |
Purchase | 10 | 230.9200 USD |
Purchase | 14 | 231.6500 USD |
Purchase | 14 | 231.1600 USD |
Purchase | 24 | 230.5608 USD |
Purchase | 41 | 230.8000 USD |
Purchase | 75 | 230.2557 USD |
Purchase | 100 | 230.0400 USD |
Purchase | 200 | 230.2000 USD |
Purchase | 200 | 230.1000 USD |
Purchase | 200 | 231.3400 USD |
Purchase | 205 | 231.2508 USD |
Purchase | 500 | 231.2333 USD |
Purchase | 530 | 230.0860 USD |
Purchase | 684 | 231.1361 USD |
Purchase | 713 | 229.4743 USD |
Purchase | 1,055 | 231.0243 USD |
Purchase | 1,200 | 230.1620 USD |
Purchase | 1,500 | 230.7153 USD |
Purchase | 1,539 | 230.9053 USD |
Purchase | 2,000 | 231.3075 USD |
Purchase | 2,169 | 231.0916 USD |
Purchase | 2,333 | 231.2302 USD |
Purchase | 2,431 | 230.1500 USD |
Purchase | 2,563 | 231.1868 USD |
Purchase | 2,608 | 231.2677 USD |
Purchase | 2,800 | 231.2582 USD |
Purchase | 3,400 | 231.2123 USD |
Purchase | 3,716 | 231.2785 USD |
Purchase | 3,906 | 231.1588 USD |
Purchase | 4,340 | 230.8075 USD |
Purchase | 4,674 | 231.2418 USD |
Purchase | 5,755 | 230.8622 USD |
Purchase | 6,026 | 230.9634 USD |
Purchase | 7,439 | 230.1647 USD |
Purchase | 8,100 | 230.6804 USD |
Purchase | 12,722 | 230.5676 USD |
Purchase | 20,013 | 230.2706 USD |
Purchase | 22,033 | 230.8661 USD |
Sale | 4 | 231.1250 USD |
Sale | 5 | 231.2840 USD |
Sale | 6 | 231.1017 USD |
Sale | 10 | 230.9200 USD |
Sale | 32 | 231.3800 USD |
Sale | 100 | 230.1300 USD |
Sale | 175 | 230.1324 USD |
Sale | 305 | 231.3315 USD |
Sale | 400 | 231.1990 USD |
Sale | 400 | 230.9800 USD |
Sale | 472 | 231.2139 USD |
Sale | 518 | 229.2200 USD |
Sale | 1,170 | 231.0928 USD |
Sale | 1,201 | 230.1629 USD |
Sale | 1,536 | 231.1681 USD |
Sale | 2,020 | 230.8258 USD |
Sale | 2,308 | 231.2263 USD |
Sale | 2,847 | 230.1748 USD |
Sale | 3,386 | 231.1610 USD |
Sale | 3,704 | 230.7486 USD |
Sale | 4,006 | 231.1531 USD |
Sale | 4,754 | 230.9174 USD |
Sale | 7,712 | 230.1500 USD |
Sale | 10,798 | 230.5688 USD |
Sale | 17,603 | 230.7921 USD |
Sale | 60,716 | 230.7992 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 24 Jun 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
| to which the option |
|
|
| |
| or derivative |
|
|
| |
| relates |
|
|
| |
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210624005517/en/
Copyright Business Wire 2021